Skip to main content
Signal8
Trium Capital LLP profile photo

Trium Capital LLP

CIK: 0001963860

Transaction Breakdown

Open Market Buys (P)0

High conviction signal

Open Market Sales (S)0

Position reduction

Option Exercises (M)0

Derivative conversions

Awards (A)0

Compensation grants

Other (G, F, J, C, D, …)0

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Mural Oncology plc logo
MURA US

Mural Oncology plc

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (0 total)

1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.

0-0 of 0

Trium Capital LLP files insider reports with the SEC as 10% Owner of Mural Oncology plc (MURA US).

About Trium Capital LLP

Trium Capital LLP (SEC CIK 0001963860) files insider reports with the SEC as 10% Owner of Mural Oncology plc (MURA US).

Signal8 holds 1 ownership filing by Trium Capital LLP, a Form 3, filed on Sep 2, 2025. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.

The business address on Trium Capital LLP's filings is in LONDON, X0.

How to read Form 4 transaction codes